Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Binge Eating Disorder
NCT03279731Phase 3Terminated
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in binge eating disorder (BED). Started Sep 2017; status: terminated.
02
Drugs
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT03279731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279731.